NCT05694819 2026-04-08
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
National Cancer Center Hospital East
Phase 2 Completed
National Cancer Center Hospital East
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
University of Colorado, Denver
Pfizer